Literature DB >> 19842797

Concomitant and feasible treatment with dasatinib and the anti-EGFR antibody cetuximab plus radiotherapy in a CML patient with multiple squamous neoplasias.

Fabio Stagno1, Paolo Vigneri, Vittorio Del Fabro, Stefania Stella, Nunzio Restuccia, Cesarina Giallongo, Michele Massimino, Salvatore Berretta, Maria Stella Pennisi, Daniele Tibullo, Elena Tirrò, Calogero Buscarino, Angelo Messina, Francesco Di Raimondo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 19842797     DOI： 10.3109/02841860903302913

Source DB:  PubMed          Journal:  Acta Oncol        ISSN： 0284-186X            Impact factor:   4.089


× No keyword cloud information.
  3 in total

1.  Successful Management of a Pregnant Patient With Chronic Myeloid Leukemia Receiving Standard Dose Imatinib.

Authors:  Stefania Stella; Elena Tirró; Michele Massimino; Silvia Rita Vitale; Sabina Russo; Maria Stella Pennisi; Adriana Puma; Chiara Romano; Sandra DI Gregorio; Vanessa Innao; Fabio Stagno; Francesco DI Raimondo; Caterina Musolino; Livia Manzella
Journal:  In Vivo       Date:  2019 Sep-Oct       Impact factor: 2.155

2.  Optimal Response in a Patient With CML Expressing BCR-ABL1 E6A2 Fusion Transcript With Nilotinib Therapy: A Case Report.

Authors:  Livia Manzella; Elena Tirrò; Silvia Rita Vitale; Adriana Puma; Maria Letizia Consoli; Loredana Tambè; Maria Stella Pennisi; Sandra DI Gregorio; Chiara Romano; Cristina Tomarchio; Francesco DI Raimondo; Fabio Stagno
Journal:  In Vivo       Date:  2020 May-Jun       Impact factor: 2.155

Review 3.  Molecular Alterations in Thyroid Cancer: From Bench to Clinical Practice.

Authors:  Elena Tirrò; Federica Martorana; Chiara Romano; Silvia Rita Vitale; Gianmarco Motta; Sandra Di Gregorio; Michele Massimino; Maria Stella Pennisi; Stefania Stella; Adriana Puma; Fiorenza Gianì; Marco Russo; Livia Manzella; Paolo Vigneri
Journal:  Genes (Basel)       Date:  2019-09-13       Impact factor: 4.096
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.